Modeling the dissemination of mammography in the United States
Authors:
Kathleen A. Cronin, Binbing Yu, Martin Krapcho, Diana L. Miglioretti, Michael P. Fay, Grant Izmirlian, Rachel Ballard-Barbash, Berta M. Geller, Eric J. Feuer
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.